Partner
Peter McWilliams & M.B.A
Venture Partner, Sanderling Ventures
- Firm
- Sanderling Ventures
- Title
- Venture Partner
- Role
- Venture partner
- Known as
- Investor
Claim, correct or request removal
Record updated 21 September 2026
About
Dr. McWilliams is the Chief Business Officer of Glycomine, a company developing orphan drugs for serious rare disorders of metabolism and protein misfolding. He was previously a Managing Director at Sanderling Ventures where he was responsible for its investment in Actimis Pharmaceuticals and, as CEO, led the company into the clinic and through to a
Is this you? Remove my profile
Loading relationship preview